DK162387D0 - Tumor-antigen, fremgangsmaade til fremstilling deraf samt anvendelse af antigenet til diagnose af humane tumorer - Google Patents

Tumor-antigen, fremgangsmaade til fremstilling deraf samt anvendelse af antigenet til diagnose af humane tumorer

Info

Publication number
DK162387D0
DK162387D0 DK162387A DK162387A DK162387D0 DK 162387 D0 DK162387 D0 DK 162387D0 DK 162387 A DK162387 A DK 162387A DK 162387 A DK162387 A DK 162387A DK 162387 D0 DK162387 D0 DK 162387D0
Authority
DK
Denmark
Prior art keywords
antigen
human tumor
diagnosis
preparing
disclosed
Prior art date
Application number
DK162387A
Other languages
English (en)
Other versions
DK162387A (da
Inventor
Garth L Nicolson
Susan M North
Peter A Steck
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of DK162387D0 publication Critical patent/DK162387D0/da
Publication of DK162387A publication Critical patent/DK162387A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Communication Control (AREA)
  • Stereophonic System (AREA)
  • Radar Systems Or Details Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Air Conditioning Control Device (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Prostheses (AREA)
DK162387A 1986-04-01 1987-03-31 Tumor-antigen, fremgangsmaade til fremstilling deraf samt anvendelse af antigenet til diagnose af humane tumorer DK162387A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/846,938 US5030559A (en) 1986-04-01 1986-04-01 Methods and compositions for the identification of metastatic human tumors

Publications (2)

Publication Number Publication Date
DK162387D0 true DK162387D0 (da) 1987-03-31
DK162387A DK162387A (da) 1987-10-02

Family

ID=25299361

Family Applications (1)

Application Number Title Priority Date Filing Date
DK162387A DK162387A (da) 1986-04-01 1987-03-31 Tumor-antigen, fremgangsmaade til fremstilling deraf samt anvendelse af antigenet til diagnose af humane tumorer

Country Status (11)

Country Link
US (1) US5030559A (da)
EP (1) EP0240341B1 (da)
JP (1) JPH0742320B2 (da)
AT (1) ATE105569T1 (da)
AU (1) AU599364B2 (da)
CA (1) CA1307478C (da)
DE (1) DE3789781T2 (da)
DK (1) DK162387A (da)
ES (1) ES2051737T3 (da)
FI (1) FI89806C (da)
NO (1) NO175642C (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE403802B (sv) * 1972-10-10 1978-09-04 Buchegger Masch Reinigung Anordning for rengoring och avfettning av maskindelar och liknande
US5648223A (en) * 1994-08-31 1997-07-15 Activated Cell Therapy, Inc. Methods for enriching breast tumor cells
US5646004A (en) * 1994-08-31 1997-07-08 Activated Cell Therapy, Inc. Methods for enriching fetal cells from maternal body fluids
US5840502A (en) * 1994-08-31 1998-11-24 Activated Cell Therapy, Inc. Methods for enriching specific cell-types by density gradient centrifugation
US5663051A (en) * 1994-08-31 1997-09-02 Activated Cell Therapy, Inc. Separation apparatus and method
DE19530273C1 (de) * 1995-08-17 1996-12-12 Univ Eberhard Karls Antikörper 105A5
DE19530272C1 (de) * 1995-08-17 1996-11-21 Univ Eberhard Karls Antikörper 103 B2
BR0115715A (pt) * 2000-11-28 2004-02-03 Wyeth Corp Análise de expressão de ácidos nucleìcos e polipeptìdeos úteis na diagnose e tratamento de câncer da próstata
HUP0303899A3 (en) * 2000-11-28 2007-05-02 Wyeth Corp Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
EP2295606A1 (en) * 2000-11-28 2011-03-16 Wyeth LLC Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
US7169722B2 (en) * 2002-01-28 2007-01-30 Guardian Industries Corp. Clear glass composition with high visible transmittance
US7482116B2 (en) 2002-06-07 2009-01-27 Dna Genotek Inc. Compositions and methods for obtaining nucleic acids from sputum
TW200821026A (en) * 2006-09-08 2008-05-16 Wyeth Corp Arginine wash in protein purification using affinity chromatography
US10745701B2 (en) 2007-06-28 2020-08-18 The Trustees Of Princeton University Methods of identifying and treating poor-prognosis cancers
US20090324596A1 (en) * 2008-06-30 2009-12-31 The Trustees Of Princeton University Methods of identifying and treating poor-prognosis cancers
EP2721140B1 (en) * 2011-06-19 2016-11-23 Abogen, Inc. Devices, solutions and methods for sample collection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697638A (en) * 1970-06-01 1972-10-10 Hoffmann La Roche Antigens
US4140753A (en) * 1976-04-30 1979-02-20 Scripps Clinic & Research Foundation Diagnostic method and reagent
US4145336A (en) * 1976-04-30 1979-03-20 Scripps Clinic And Research Foundation Carcinoembryonic antigen isomer
IN150740B (da) * 1978-11-24 1982-12-04 Hoffmann La Roche
US4444744A (en) * 1980-03-03 1984-04-24 Goldenberg Milton David Tumor localization and therapy with labeled antibodies to cell surface antigens
DE3586216T2 (de) * 1984-05-01 1992-12-10 Ciba Corning Diagnostics Corp Brusttumorassoziiertes antigen und monoklonale antikoerper dazu.

Also Published As

Publication number Publication date
NO871352D0 (no) 1987-03-31
EP0240341A2 (en) 1987-10-07
FI871411A0 (fi) 1987-03-31
EP0240341A3 (en) 1989-07-19
NO175642B (da) 1994-08-01
NO175642C (no) 1994-11-09
JPS62253395A (ja) 1987-11-05
ATE105569T1 (de) 1994-05-15
DE3789781D1 (de) 1994-06-16
FI871411A (fi) 1987-10-02
AU599364B2 (en) 1990-07-19
JPH0742320B2 (ja) 1995-05-10
AU7075387A (en) 1987-10-08
EP0240341B1 (en) 1994-05-11
DE3789781T2 (de) 1994-11-10
NO871352L (no) 1987-10-02
US5030559A (en) 1991-07-09
DK162387A (da) 1987-10-02
ES2051737T3 (es) 1994-07-01
FI89806C (fi) 1993-11-25
FI89806B (fi) 1993-08-13
CA1307478C (en) 1992-09-15

Similar Documents

Publication Publication Date Title
DK162387A (da) Tumor-antigen, fremgangsmaade til fremstilling deraf samt anvendelse af antigenet til diagnose af humane tumorer
WO1998037418A3 (en) Compounds for immunodiagnosis of prostate cancer and methods for their use
EP0288082A3 (en) A tumor specific assay for ca125 ovarian cancer antigen
WO1999004265A8 (en) Cancer associated nucleic acids and polypeptides
DE3751908D1 (de) Chimärisches Murine-Mensch-Immunoglobulin, spezifisch für tumorassoziertes 17-1A Antigen
EP0344940A3 (en) Antibodies to human papillomavirus latent proteins, diagnostic systems and methods
EP0378924A3 (en) Detection of neurological disease or dysfunction
ES8609731A1 (es) Un metodo para diagnosticar una condicion neoplastica en un hospedante mamifero
WO1989003846A3 (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
WO1997008318A3 (en) Compounds and methods for treatment and diagnosis of prostate cancer
NO870476D0 (no) Fremgangsmaate for fremstilling av kryss-beskyttende humane monoklonale antistoffpreparater.
DK314586A (da) Monoklonale antistoffer og antigener for humane lungecarcinomer, der ikke er af typen med smaa celler
IE802533L (en) Cancer cell antigens
DK172686A (da) Antigen opnaaet ud fra humant vaev, fremgangsmaade til under anvendelse af antigenet at fremstille monoklonale antistoffer til diagnose og behandling af cancer, fremgangsmaade til paavisning af cancer, samt antistoffer mod antigenet
CA2294514A1 (en) Method for identification of cellular protein antigens and presence of antibodies to specific cellular protein antigens in serum
EP0218158A3 (en) Human monoclonal antibody, B-cell line for producing this antibody and method for preparing this B-cell line and antibody.
ATE206138T1 (de) Helicobacter pylori antigen
OA08704A (en) Polypeptidic composition useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of antimerozoite antibodies.
NO914094L (no) Nytt monoklonalt antistoff mot nytt antigen forbundet medhumantumorer
DK182188A (da) Humant tumorassocieret antigen
IT8121549A0 (it) Metodo integrato per l'analisi degli anticorpi antistreptolisinici e mezzi adatti allo scopo.
IL79565A0 (en) Monoclonal antibodies,method for their preparation and use thereof for tumor detection
FI875541A (fi) Foerfarande foer diagnos och testning av en anslutningsenhet.
IT8885561A0 (it) Sistema integrato e metodo per lapreparazione di elementi costitutivi di capi di abbigliamento, particolarmente per nuovi modelli.

Legal Events

Date Code Title Description
PBP Patent lapsed
AHB Application shelved due to non-payment